Status:

RECRUITING

Acuvue Oaysis Contact Lens Wearers Being Refit Into P7 Contact Lenses

Lead Sponsor:

Southern College of Optometry

Collaborating Sponsors:

Eminent Ophthalmic Services

Conditions:

Contact Lens Comfort

Eligibility:

All Genders

18-40 years

Phase:

NA

Brief Summary

Determine the likelihood of successfully refitting a satisfied AOA CL wearers into P7A CLs

Detailed Description

PRECISION7m for Astigmatism is a 1-week, silicone hydrogel (serafilcon A), daily wear, contact lens (CL) with extended wear approval made of a novel material that incorporates the Activ-Flo System. Th...

Eligibility Criteria

Inclusion

  • • Adults, 18- to 40-year-old, AOA CL wearers with best-corrected 20/20 visual acuity or better.
  • Participants will be required to have worn AOA CLs for at least 3 months in the past year and currently wearing these CLs.
  • All participants will be required to have a CLDEQ-8 score \<12 while wearing their habitual CLs (AOA CLs) and to indicate that they are satisfied with AOA CLs (Yes/No).
  • Participants will be required to be able to wear P7A CLs (astigmatism ≥0.75D OD/OS).
  • Astigmatism ranging from 0.75 D to 2.50 D in each eye
  • Participants will be required to wear the study CLs for ≥13 hours with no overnight wear
  • Participants will be willing to wear the CL every day of the week, except during the washout period
  • Participants will be required to provide a glasses prescription that is less than 3 years old
  • \-

Exclusion

  • \- Have presbyopia and/or need a reading add as determined during their initial manifest refraction
  • Have worn P7A in the past
  • Are past rigid CL wearers
  • Have a history of being diagnosed with dry eye or ocular allergies
  • Have known systemic health conditions that are thought to alter tear film physiology
  • Have a history of viral eye disease
  • Have a history of ocular surgery
  • Have a history of severe ocular trauma
  • Have a history of corneal dystrophies or degenerations
  • Have active ocular infection or inflammation
  • Are currently using isotretinoin-derivatives or ocular medications
  • Are pregnant or breast feeding

Key Trial Info

Start Date :

April 15 2025

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

November 30 2025

Estimated Enrollment :

40 Patients enrolled

Trial Details

Trial ID

NCT06955403

Start Date

April 15 2025

End Date

November 30 2025

Last Update

November 26 2025

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

The Southern College of Optometry

Memphis, Tennessee, United States, 38104